Psyence Biomedical (Psyence Biomedical) EV-to-EBITDA : (As of May. 01, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Psyence Biomedical's enterprise value is $12.99 Mil. Psyence Biomedical does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Psyence Biomedical's EV-to-EBITDA at this moment.

The historical rank and industry rank for Psyence Biomedical's EV-to-EBITDA or its related term are showing as below:

PBM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -14.7 Med: 0 Max: 0
Current: -4.16

PBM's EV-to-EBITDA is ranked worse than
100% of 468 companies
in the Biotechnology industry
Industry Median: 9.155 vs PBM: -4.16

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-01), Psyence Biomedical's stock price is $0.8994. Psyence Biomedical does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Psyence Biomedical's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Psyence Biomedical EV-to-EBITDA Historical Data

The historical data trend for Psyence Biomedical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical EV-to-EBITDA Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

EV-to-EBITDA

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
EV-to-EBITDA	-	-	-

Competitive Comparison of Psyence Biomedical's EV-to-EBITDA

For the Biotechnology subindustry, Psyence Biomedical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's EV-to-EBITDA falls into.

Psyence Biomedical EV-to-EBITDA Calculation

Psyence Biomedical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	12.990	/
	=

Psyence Biomedical (NAS:PBM) EV-to-EBITDA Explanation

Psyence Biomedical's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.8994	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Psyence Biomedical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024